chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Pain, Pain in extremity
Clinical narrative: Very painful arm that radiates to hand, chest, and back; Very painful arm that radiates to hand, chest, and back; Very painful arm that radiates to hand, chest, and back; Very painful arm that radiates to hand, chest, and back; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Oct2021 12:00 (Lot number: FHS020) at the age of 32 years as dose 3 (booster), single for covid-19 immunisation. The patient relevant medical history was not reported. Concomitant medication(s) included: SYNTHROID; METFORMIN; SPIROLACTONE; CYMBALTA. Past drug history included: Amoxicillin, reaction(s): "Allergy", notes: Known allergies: Amoxicillin. Vaccination history included: Bnt162b2 (Dose Number: 2, Prev dose product=COVID 19, Prev dose brand= Pfizer, Prev dose brand unknown=False, Prev dose lot number= ER8730, Prev dose lot unknown=False, Prev dose administration date=30Mar2021, Prev dose number=2), administration date: 30Mar2021, when the patient was 32 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Prev dose product=COVID 19, Prev dose brand= Pfizer, Prev dose brand unknown=False, Prev dose lot number= EN6205, Prev dose lot unknown=False, Prev dose administration date=09Mar2021, Prev dose number=1, Prev dose vaccine location=Left arm), administration date: 09Mar2021, when the patient was 32 years old, for Covid-19 Immunization.  The following information was reported: PAIN IN EXTREMITY (non-serious), PAIN (non-serious), CHEST PAIN (non-serious), BACK PAIN (non-serious) all with onset 25Oct2021 16:00 PM, outcome "not recovered" and all described as "Very painful arm that radiates to hand, chest, and back". Therapeutic measures were not taken as a result of pain in extremity, pain, chest pain, back pain.  Additional Information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient was not received treatment.  Follow-Up (02Nov2021): Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Myalgia, Pyrexia
Clinical narrative: fever; cough; chills; muscle aches This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "fever"; COUGH (non-serious), outcome "not recovered", described as "cough"; CHILLS (non-serious), outcome "recovered", described as "chills"; MYALGIA (non-serious), outcome "recovered", described as "muscle aches".  Additional information: Patient received the 1st dose of pfizer covid vaccine and had a reaction: fever, cough, chills, muscle aches for 5 days. Reports ongoing cough. wanting to know if it was safe to get 2nd dose given his reactions to first dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Muscular weakness, Myalgia, Pain, SARS-CoV-2 test
Clinical narrative: Muscle weakness; Hives; muscle pain; Fatigue; pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Sep2021 18:30 (Lot number: FF2587) at the age of 53 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Auto immune disease" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Bnt162b2 (Prev dose Lot number: FC3181, Prev dose Administration time: 18:30, Prev dose Dose number: 1, Prev dose Vaccine location: Left arm), administration date: 18Aug2021, when the patient was 53 years old, for Covid-19 Immunization. The following information was reported: MYALGIA (non-serious) with onset 29Sep2021 23:00, outcome "not recovered", described as "muscle pain"; FATIGUE (non-serious) with onset 29Sep2021 23:00, outcome "not recovered", described as "Fatigue"; PAIN (non-serious) with onset 29Sep2021 23:00, outcome "not recovered", described as "pain"; URTICARIA (non-serious) with onset 11Oct2021, outcome "not recovered", described as "Hives"; MUSCULAR WEAKNESS (non-serious) with onset 30Oct2021, outcome "unknown", described as "Muscle weakness". The events "muscle pain", "fatigue", "pain", "hives" and "muscle weakness" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of myalgia, fatigue, pain, muscular weakness. Therapeutic measures were taken as a result of urticaria.  Additional Information: Patient had COVID prior vaccination. Patient was tested for COVID post vaccination. Covid test post vaccination: covid test type post vaccination-Nasal Swab, covid test name post vaccination-SARS Coronavirus 2-PRL, covid test date- 14Oct2021, Covid test result - Negative. The patient did not take any other vaccine in four weeks.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Muscle weakness; Hives; muscle pain; Fatigue; pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Sep2021 18:30 (Lot number: FF2587) at the age of 53 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Auto immune disease" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Bnt162b2 (Prev dose Lot number: FC3181, Prev dose Administration time: 18:30, Prev dose Dose number: 1, Prev dose Vaccine location: Left arm), administration date: 18Aug2021, when the patient was 53 years old, for Covid-19 Immunization. The following information was reported: MYALGIA (non-serious) with onset 29Sep2021 23:00, outcome "not recovered", described as "muscle pain"; FATIGUE (non-serious) with onset 29Sep2021 23:00, outcome "not recovered", described as "Fatigue"; PAIN (non-serious) with onset 29Sep2021 23:00, outcome "not recovered", described as "pain"; URTICARIA (non-serious) with onset 11Oct2021, outcome "not recovered", described as "Hives"; MUSCULAR WEAKNESS (non-serious) with onset 30Oct2021, outcome "unknown", described as "Muscle weakness". The events "muscle pain", "fatigue", "pain", "hives" and "muscle weakness" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of myalgia, fatigue, pain, muscular weakness. Therapeutic measures were taken as a result of urticaria.  Additional Information: Patient had COVID prior vaccination. Patient was tested for COVID post vaccination. Covid test post vaccination: covid test type post vaccination-Nasal Swab, covid test name post vaccination-SARS Coronavirus 2-PRL, covid test date- 14Oct2021, Covid test result - Negative. The patient did not take any other vaccine in four weeks.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Illness, Intermenstrual bleeding, Pyrexia
Clinical narrative: Ill-Fever of 102; diarrhea; vomiting; Break through bleeding; Ill-Fever of 102; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Apr2021 09:15 (Lot number: ER8731) at the age of 35 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Pfizer,, lot_number #EN8733,, administration date=29Mar2021,, time=09:15, dose_number=1,, Leftarm), administration date: 29Mar2021, when the patient was 35 years old, for COVID-19 IMMUNIZATION, reaction(s): "Break through bleeding", "Cramping". The following information was reported: PYREXIA (non-serious), ILLNESS (non-serious), outcome "recovered with sequelae" and all described as "Ill-Fever of 102"; DIARRHOEA (non-serious), outcome "recovered with sequelae", described as "diarrhea"; VOMITING (non-serious), outcome "recovered with sequelae", described as "vomiting"; INTERMENSTRUAL BLEEDING (non-serious), outcome "recovered with sequelae", described as "Break through bleeding". The events "ill-fever of 102", "diarrhea", "vomiting", "break through bleeding" and "ill-fever of 102" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, diarrhoea, vomiting, intermenstrual bleeding, illness.  Additional information: I had break through bleeding and cramping within 24 hours of 1 dose which lead to heavy bleeding for the next 4 weeks up to the time of dose 2. I continued to cramp and bleed for 2 more weeks. I also became extremely ill-fever of 102, diarrhea and vomiting for 48 hours after second dose. I continue to have breakthrough bleeding randomly between menstrual cycles and I'm having much worse menstrual cycle side effects examples debilitating cramps nausea and diarrhea that I did not have prior to being vaccinated with Pfizer COVID- 19 vaccine. No other vaccine in four weeks. No covid prior vaccination and No covid tested post vaccination. No Known allergies.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101449345 similar report from same reporter
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Ill-Fever of 102; diarrhea; vomiting; Break through bleeding; Ill-Fever of 102; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Apr2021 09:15 (Lot number: ER8731) at the age of 35 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Pfizer,, lot_number #EN8733,, administration date=29Mar2021,, time=09:15, dose_number=1,, Leftarm), administration date: 29Mar2021, when the patient was 35 years old, for COVID-19 IMMUNIZATION, reaction(s): "Break through bleeding", "Cramping". The following information was reported: PYREXIA (non-serious), ILLNESS (non-serious), outcome "recovered with sequelae" and all described as "Ill-Fever of 102"; DIARRHOEA (non-serious), outcome "recovered with sequelae", described as "diarrhea"; VOMITING (non-serious), outcome "recovered with sequelae", described as "vomiting"; INTERMENSTRUAL BLEEDING (non-serious), outcome "recovered with sequelae", described as "Break through bleeding". The events "ill-fever of 102", "diarrhea", "vomiting", "break through bleeding" and "ill-fever of 102" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, diarrhoea, vomiting, intermenstrual bleeding, illness.  Additional information: I had break through bleeding and cramping within 24 hours of 1 dose which lead to heavy bleeding for the next 4 weeks up to the time of dose 2. I continued to cramp and bleed for 2 more weeks. I also became extremely ill-fever of 102, diarrhea and vomiting for 48 hours after second dose. I continue to have breakthrough bleeding randomly between menstrual cycles and I'm having much worse menstrual cycle side effects examples debilitating cramps nausea and diarrhea that I did not have prior to being vaccinated with Pfizer COVID- 19 vaccine. No other vaccine in four weeks. No covid prior vaccination and No covid tested post vaccination. No Known allergies.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101449345 similar report from same reporter
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Tenderness
Clinical narrative: low grade fever; soreness in my left arm; On 10/25 and 10/26 I experience tenderness under my left armpit.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Oct2021 16:00 (Lot number: 320308D) at the age of 42 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU, administration date 09Oct2021; LEXAPRO. Past drug history included: No. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6205, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 15Apr2021, when the patient was 41 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9267, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 25Mar2021, when the patient was 41 years old, for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious) with onset 25Oct2021, outcome "not recovered", described as "low grade fever"; PAIN IN EXTREMITY (non-serious) with onset 25Oct2021, outcome "not recovered", described as "soreness in my left arm"; TENDERNESS (non-serious) with onset 25Oct2021, outcome "not recovered", described as "On 10/25 and 10/26 I experience tenderness under my left armpit.". Therapeutic measures were not taken as a result of pyrexia, pain in extremity, tenderness.Prior to vaccination, the patient was not diagnosed with covid-19 and since the vaccination, patient was not diagnosed with covid-19.  No follow-up attempts are possible. No further information is expected. Device Date : 26Oct2021.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Swelling of armpit of injected arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Oct2021 12:00 (Lot number: FI-2593) at the age of 34 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single, Batch/Lot No: en6202), administration date: 05Mar2021, when the patient was 33 years old, for COVID-19 immunization; Bnt162b2 (dose 2, single, Batch/Lot No: ep7534), administration date: 26Mar2021, when the patient was 33 years old, for COVID-19 immunization. The following information was reported: SWELLING (non-serious) with onset 25Oct2021, outcome "not recovered", described as "Swelling of armpit of injected arm". Therapeutic measures were not taken as a result of swelling.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient was not diagnosed with COVID-19 and not been tested since the vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Chills, Cough, Myalgia
Clinical narrative: Chills; High Fever; Cough; Muscle ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Oct2021 (Lot number: 30130BA) at the age of 28 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing), notes: Verbatim: High Blood pressure. Concomitant medication(s) included: HYDROCHLOROTHIAZIDE taken for hypertension; ABILIFY. The following information was reported: PYREXIA (non-serious) with onset Oct2021, outcome "unknown", described as "High Fever"; COUGH (non-serious) with onset Oct2021, outcome "not recovered", described as "Cough"; MYALGIA (non-serious) with onset Oct2021, outcome "not recovered", described as "Muscle ache"; CHILLS (non-serious) with onset 15Oct2021, outcome "recovered" (20Oct2021), described as "Chills". The events "high fever", "cough", "muscle ache" and "chills" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, cough, myalgia, chills.  Additional Information: NDC number, UPC number and Expiry Date for suspect were Unknown. The patient took no prior vaccination (within 4 weeks). When probed for the concern, consumer stated he got the (first dose) Pfizer Vaccine on 15Oct (further not clarified) 2021 and wanted to report adverse reaction to this. Patient had high fever and still have like cough, muscle ache, had chills and it lasted about 5 days. consumer's (patient) height and weight, consumer stated, "My weight is, I think like 299 I believe probably." When probed for any concomitant medication, consumer stated, "patient took "Abilify" (further not clarified, hence not captured in the tab). When probed for any laboratory test, consumer stated, "It was long ago. When probed for any treatment for the event, consumer stated, "No, he didn't take. He went to the urgent care. Consumer stated, there was a question. Should he even take the second dose vaccine, was it safe to do so.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; High Fever; Cough; Muscle ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Oct2021 (Lot number: 30130BA) at the age of 28 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing), notes: Verbatim: High Blood pressure. Concomitant medication(s) included: HYDROCHLOROTHIAZIDE taken for hypertension; ABILIFY. The following information was reported: PYREXIA (non-serious) with onset Oct2021, outcome "unknown", described as "High Fever"; COUGH (non-serious) with onset Oct2021, outcome "not recovered", described as "Cough"; MYALGIA (non-serious) with onset Oct2021, outcome "not recovered", described as "Muscle ache"; CHILLS (non-serious) with onset 15Oct2021, outcome "recovered" (20Oct2021), described as "Chills". The events "high fever", "cough", "muscle ache" and "chills" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, cough, myalgia, chills.  Additional Information: NDC number, UPC number and Expiry Date for suspect were Unknown. The patient took no prior vaccination (within 4 weeks). When probed for the concern, consumer stated he got the (first dose) Pfizer Vaccine on 15Oct (further not clarified) 2021 and wanted to report adverse reaction to this. Patient had high fever and still have like cough, muscle ache, had chills and it lasted about 5 days. consumer's (patient) height and weight, consumer stated, "My weight is, I think like 299 I believe probably." When probed for any concomitant medication, consumer stated, "patient took "Abilify" (further not clarified, hence not captured in the tab). When probed for any laboratory test, consumer stated, "It was long ago. When probed for any treatment for the event, consumer stated, "No, he didn't take. He went to the urgent care. Consumer stated, there was a question. Should he even take the second dose vaccine, was it safe to do so.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Oct2021 14:45 (Lot number: FF8841) at the age of 61 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: PYREXIA (non-serious) with onset 25Oct2021 02:45, outcome "recovering", described as "Fever". Therapeutic measures were not taken as a result of pyrexia.  Additional information: Other vaccine on same date was administered to the patient. Patient was administered a Pfizer vaccine (lot number=1693) on 25Oct2021, in Left arm, dose 1. No other vaccine were administered in 4 weeks. Other medications were given in two weeks. The patient did not have covid prior vaccination and was not tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Pyrexia
Clinical narrative: I ran a fever; body aches; swelling right under my left arm pit thats about the size of a grapefruit the area is sore to the touch; This is a spontaneous report received from a contactable Consumer or other non HCP. The reporter is the patient.  A 46 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Oct2021 15:00 (Lot number: 30145ba) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin; "If Covid prior vaccination: Yes" (unspecified if ongoing), notes: If Covid prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Bnt162b2 (Previous dose Number: 1, Batch/Lot No: 30145ba, Location of injection: Arm Left, Vaccine Administration Time: 03:00 PM), administration date: 01Oct2021, when the patient was 46 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 23Oct2021 23:00, outcome "not recovered", described as "I ran a fever"; PAIN (non-serious) with onset 23Oct2021 23:00, outcome "not recovered", described as "body aches"; LYMPHADENOPATHY (non-serious) with onset 23Oct2021 23:00, outcome "not recovered", described as "swelling right under my left arm pit thats about the size of a grapefruit the area is sore to the touch". Therapeutic measures were not taken as a result of pyrexia, pain, lymphadenopathy.  Additional information: The patient was not received other vaccine in four weeks. The patient had Covid prior to vaccination. The patient was not tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Influenza like illness, Nausea, Pain
Clinical narrative: flu like symptoms; 104 degree fever; body aches; nausea; head ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 46-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Oct2021 11:00 (Lot number: FH8020) at the age of 46 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN2601, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 11Feb2021, when the patient was 46 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9263, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 21Jan2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "flu like symptoms"; PYREXIA (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "104 degree fever"; PAIN (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "body aches"; NAUSEA (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "nausea"; HEADACHE (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "head ache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of influenza like illness, pyrexia, pain, nausea, headache.  Additional information: Seriousness Criteria-Results in death was reported as no. Seriousness Criteria-Life threatening was NO. Seriousness criteria-Caused/prolonged hospitalization was as no. Seriousness Criteria-Disabling/Incapacitating was NO. Seriousness criteria-Congenital anomaly/birth defect was reported as NO. Facility where the most recent COVID-19 vaccine was administered (withheld). the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment ae. No known allergies. No other medical history. Prior to vaccination, was the patient diagnosed with COVID-19 was reported as No. Since the vaccination, has the patient been tested for COVID-19 was reported as no.?  Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: flu like symptoms; 104 degree fever; body aches; nausea; head ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 46-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Oct2021 11:00 (Lot number: FH8020) at the age of 46 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN2601, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 11Feb2021, when the patient was 46 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9263, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 21Jan2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "flu like symptoms"; PYREXIA (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "104 degree fever"; PAIN (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "body aches"; NAUSEA (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "nausea"; HEADACHE (non-serious) with onset 25Oct2021 03:00, outcome "recovering", described as "head ache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of influenza like illness, pyrexia, pain, nausea, headache.  Additional information: Seriousness Criteria-Results in death was reported as no. Seriousness Criteria-Life threatening was NO. Seriousness criteria-Caused/prolonged hospitalization was as no. Seriousness Criteria-Disabling/Incapacitating was NO. Seriousness criteria-Congenital anomaly/birth defect was reported as NO. Facility where the most recent COVID-19 vaccine was administered (withheld). the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment ae. No known allergies. No other medical history. Prior to vaccination, was the patient diagnosed with COVID-19 was reported as No. Since the vaccination, has the patient been tested for COVID-19 was reported as no.?  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Headache; chills; fatigue; fever (100F); This is a spontaneous report from a Non-contactable consumer. This male consumer (patient) reported for himself.  An adult male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Oct2021 15:00 (Lot number: FF2590) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 01Apr2021, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 11Mar2021, for COVID-19 Immunization. The following information was reported: HEADACHE (non-serious) with onset 16Oct2021 04:00, outcome "recovered" (Oct2021), described as "Headache"; CHILLS (non-serious) with onset 16Oct2021 04:00, outcome "recovered" (Oct2021), described as "chills"; FATIGUE (non-serious) with onset 16Oct2021 04:00, outcome "recovered" (Oct2021), described as "fatigue"; PYREXIA (non-serious) with onset 16Oct2021 04:00, outcome "recovered" (Oct2021), described as "fever (100F)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, chills, fatigue, pyrexia.  Additional information: Patient did not have other vaccine in four weeks. Patient did not have covid prior vaccination. Patient was tested for covid post vaccination.   No follow-up attempts are Possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Headache; chills; fatigue; fever (100F); This is a spontaneous report from a Non-contactable consumer. This male consumer (patient) reported for himself.  An adult male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Oct2021 15:00 (Lot number: FF2590) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 01Apr2021, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 11Mar2021, for COVID-19 Immunization. The following information was reported: HEADACHE (non-serious) with onset 16Oct2021 04:00, outcome "recovered" (Oct2021), described as "Headache"; CHILLS (non-serious) with onset 16Oct2021 04:00, outcome "recovered" (Oct2021), described as "chills"; FATIGUE (non-serious) with onset 16Oct2021 04:00, outcome "recovered" (Oct2021), described as "fatigue"; PYREXIA (non-serious) with onset 16Oct2021 04:00, outcome "recovered" (Oct2021), described as "fever (100F)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, chills, fatigue, pyrexia.  Additional information: Patient did not have other vaccine in four weeks. Patient did not have covid prior vaccination. Patient was tested for covid post vaccination.   No follow-up attempts are Possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: experiencing DOB; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2, Solution for injection) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSPNOEA (non-serious), outcome "unknown", described as "experiencing DOB". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bedridden, Chills, Eating disorder, Epistaxis
Clinical narrative: right nostril had a little blood in it, it would come out and then stop; She stayed in bed; Did not eat or drink; Slight headache; Fatigue; Joint pain; Muscle pain; Vomiting a little bit; Chills; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 83 year-old female patient received bnt162b2 (COMIRNATY), administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization. The following information was reported: EPISTAXIS (non-serious) with onset 2021, outcome "not recovered", described as "right nostril had a little blood in it, it would come out and then stop"; BEDRIDDEN (non-serious) with onset 2021, outcome "unknown", described as "She stayed in bed"; EATING DISORDER (non-serious) with onset 2021, outcome "unknown", described as "Did not eat or drink"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "Slight headache"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "Fatigue"; ARTHRALGIA (non-serious) with onset 2021, outcome "unknown", described as "Joint pain"; MYALGIA (non-serious) with onset 2021, outcome "unknown", described as "Muscle pain"; VOMITING (non-serious) with onset 2021, outcome "unknown", described as "Vomiting a little bit"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "Chills". Additional information: patient states 27Oct2021 will be 8 months since her second Pfizer Covid vaccine injection. After second dose of the Pfizer Covid vaccine she experienced slight headache, fatigue, joint pain, muscle pain, vomiting a little bit, chills muscle aches. She stayed in bed and did not eat or drink. Also said her right nostril had a little blood in it, it would come out and then stop. Next day I was fine then every other week my right nostril would bleed a little bit, and that has happened every two to three weeks with the last time being last week, for the last 8 month, patient also states her daughter had some of the same symptoms but declined to provide demographic information. Her daughter took the Moderna booster. Caller stated her granddaughter did not have the same side effects.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Vomiting
Clinical narrative: right nostril had a little blood in it, it would come out and then stop; She stayed in bed; Did not eat or drink; Slight headache; Fatigue; Joint pain; Muscle pain; Vomiting a little bit; Chills; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 83 year-old female patient received bnt162b2 (COMIRNATY), administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization. The following information was reported: EPISTAXIS (non-serious) with onset 2021, outcome "not recovered", described as "right nostril had a little blood in it, it would come out and then stop"; BEDRIDDEN (non-serious) with onset 2021, outcome "unknown", described as "She stayed in bed"; EATING DISORDER (non-serious) with onset 2021, outcome "unknown", described as "Did not eat or drink"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "Slight headache"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "Fatigue"; ARTHRALGIA (non-serious) with onset 2021, outcome "unknown", described as "Joint pain"; MYALGIA (non-serious) with onset 2021, outcome "unknown", described as "Muscle pain"; VOMITING (non-serious) with onset 2021, outcome "unknown", described as "Vomiting a little bit"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "Chills". Additional information: patient states 27Oct2021 will be 8 months since her second Pfizer Covid vaccine injection. After second dose of the Pfizer Covid vaccine she experienced slight headache, fatigue, joint pain, muscle pain, vomiting a little bit, chills muscle aches. She stayed in bed and did not eat or drink. Also said her right nostril had a little blood in it, it would come out and then stop. Next day I was fine then every other week my right nostril would bleed a little bit, and that has happened every two to three weeks with the last time being last week, for the last 8 month, patient also states her daughter had some of the same symptoms but declined to provide demographic information. Her daughter took the Moderna booster. Caller stated her granddaughter did not have the same side effects.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever; chills; body aches; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 22Oct2021 (Lot number: FF8841) at the age of 27 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing), notes: Known allergies: Sulfa. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3248), administration date: 08Feb2021, when the patient was 27 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3248), administration date: 20Jan2021, when the patient was 27 years old, for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious) with onset 22Oct2021, outcome "recovering", described as "Fever"; CHILLS (non-serious) with onset 22Oct2021, outcome "recovering", described as "chills"; PAIN (non-serious) with onset 22Oct2021, outcome "recovering", described as "body aches"; HEADACHE (non-serious) with onset 22Oct2021, outcome "recovering", described as "headache". Therapeutic measures were not taken as a result of pyrexia, chills, pain, headache.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Nausea, Pain
Clinical narrative: Widespread joint pain-achy.; Nausea and vomiting; Nausea and vomiting; Headache; Fatigue; Widespread joint pain-achy.; This is a spontaneous report received from contactable reporter(s) (Other HCP and Physician). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Oct2021 11:00 (Lot number: Ew0173) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: DYAZIDE; WELLBUTRIN; LEXAPRO; AMITIZA; PRILOSEC. Past drug history included: Erythromycin, reaction(s): "Known allergies: Erythromycin", notes: Known allergies: Erythromycin; Bactrim, reaction(s): "Known allergies: Bactrim", notes: Known allergies: Bactrim. Vaccination history included: Bnt162b2 (Dose 1, Lot number: EJ1686, Administration time: 12:00 PM, Vaccine location: Left arm, Route of administration: Intramuscular), administration date: 05Jan2021, when the patient was 45 years old, for COVID-19 Immunization; Bnt162b2 (Dose 2, Lot number: EL9262, Administration time: 12:00 PM, Vaccine location: Left arm, Route of administration: Intramuscular), administration date: 26Jan2021, when the patient was 45 years old, for COVID-19 Immunization. The following information was reported: ARTHRALGIA (non-serious), PAIN (non-serious) all with onset 24Oct2021, outcome "not recovered" and all described as "Widespread joint pain-achy."; NAUSEA (non-serious), VOMITING (non-serious) all with onset 24Oct2021, outcome "not recovered" and all described as "Nausea and vomiting"; HEADACHE (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Headache"; FATIGUE (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Fatigue". Therapeutic measures were not taken as a result of arthralgia, nausea, vomiting, headache, fatigue, pain.  Additional information: It was stated that patient did not receive other vaccine in four weeks of COVID vaccination. Patient was not diagnosed with COVID prior to vaccination and not tested with COVID since vaccination. Facility where the most recent COVID-19 vaccine was administered Public Health Clinic/Veterans Administration facility  Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Widespread joint pain-achy.; Nausea and vomiting; Nausea and vomiting; Headache; Fatigue; Widespread joint pain-achy.; This is a spontaneous report received from contactable reporter(s) (Other HCP and Physician). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Oct2021 11:00 (Lot number: Ew0173) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: DYAZIDE; WELLBUTRIN; LEXAPRO; AMITIZA; PRILOSEC. Past drug history included: Erythromycin, reaction(s): "Known allergies: Erythromycin", notes: Known allergies: Erythromycin; Bactrim, reaction(s): "Known allergies: Bactrim", notes: Known allergies: Bactrim. Vaccination history included: Bnt162b2 (Dose 1, Lot number: EJ1686, Administration time: 12:00 PM, Vaccine location: Left arm, Route of administration: Intramuscular), administration date: 05Jan2021, when the patient was 45 years old, for COVID-19 Immunization; Bnt162b2 (Dose 2, Lot number: EL9262, Administration time: 12:00 PM, Vaccine location: Left arm, Route of administration: Intramuscular), administration date: 26Jan2021, when the patient was 45 years old, for COVID-19 Immunization. The following information was reported: ARTHRALGIA (non-serious), PAIN (non-serious) all with onset 24Oct2021, outcome "not recovered" and all described as "Widespread joint pain-achy."; NAUSEA (non-serious), VOMITING (non-serious) all with onset 24Oct2021, outcome "not recovered" and all described as "Nausea and vomiting"; HEADACHE (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Headache"; FATIGUE (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Fatigue". Therapeutic measures were not taken as a result of arthralgia, nausea, vomiting, headache, fatigue, pain.  Additional information: It was stated that patient did not receive other vaccine in four weeks of COVID vaccination. Patient was not diagnosed with COVID prior to vaccination and not tested with COVID since vaccination. Facility where the most recent COVID-19 vaccine was administered Public Health Clinic/Veterans Administration facility  Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Coughing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: COUGH (non-serious), outcome "unknown", described as "Coughing".  Additional information: Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Headache, Neurological examination, Rhinalgia, Trigeminal neuralgia
Clinical narrative: Trigeminal neuralgia; The pain was sharp and shooting into forehead, right side only/chewing caused excruciating pain in forehead; Intense pain beside nose, possibly ethnoid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Oct2021 11:15 (Lot number: 30130BA) at the age of 63 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLUCELVAX QUADRIVALENT, administration date 14Sep2021. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0153, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 03Apr2021, when the patient was 63 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6206, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 06Mar2021, when the patient was 63 years old, for COVID-19 immunization. The following information was reported: RHINALGIA (non-serious) with onset 11Oct2021 12:00, outcome "not recovered", described as "Intense pain beside nose, possibly ethnoid"; HEADACHE (non-serious) with onset 14Oct2021, outcome "not recovered", described as "The pain was sharp and shooting into forehead, right side only/chewing caused excruciating pain in forehead"; TRIGEMINAL NEURALGIA (non-serious) with onset 18Oct2021, outcome "not recovered", described as "Trigeminal neuralgia". The events "intense pain beside nose, possibly ethnoid", "the pain was sharp and shooting into forehead, right side only/chewing caused excruciating pain in forehead" and "trigeminal neuralgia" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rhinalgia, headache, trigeminal neuralgia. No follow-up attempts are possible. No further information is expected.